Evidence map›Paper›PMID 38409695›Full record

ReviewPharmaceutical nanotechnology2025

Eco-friendly Synthesis of

Puja Kumari, Laxmi Devi, Renu Kadian, Aafrin Waziri, Md Sabir Alam

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutical nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Puja KumariDepartment of Pharmaceutics, SGT College of Pharmacy, SGT University, Gurgaon-Badli Road Chandu, Budhera, Gurugram, 122505, Haryana, India.ORCID 0009-0001-5042-2645
Laxmi DeviFaculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 226 026, India.ORCID 0000-0002-4084-2259
Renu KadianRam Gopal College of Pharmacy, Sultanpur, Gurugram, 122506, Haryana, India.ORCID 0000-0002-5159-5409
Aafrin WaziriUniversity School of Biotechnology, Guru Gobind Singh Indraprastha University, Golf Course Rd, Sector 16 C, Dwarka, 110078, Delhi, India.ORCID 0000-0001-5993-7576
Md Sabir AlamDepartment of Pharmaceutics, SGT College of Pharmacy, SGT University, Gurgaon-Badli Road Chandu, Budhera, Gurugram, 122505, Haryana, India.ORCID 0000-0002-2845-0156
Shree Guru Gobind Singh Tricentenary University · INGuru Gobind Singh Indraprastha University · INIndian Institute of Technology Dhanbad · INIntegral University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of producing the metallic nanoparticles (MNPs) in a sustainable and environment- friendly process is very desirable due to environmental hazards posed by climatic changes. Biomedical one of the fields classified under nanoscience, nanoparticles have a potential synthetic application, which makes it a vast area of research. These particles can be prepared using chemical, physical, and biological methods. One of the methods of synthesis of nanoparticles is by the use of plant extracts, known as green synthesis. Because of its low cost and nontoxicity, it has gained attention in recent times. This review was conducted to find the possible outcomes and uses of metallic nanoparticles synthesized using different parts like gum, root, stem, leaf, fruits, etc. of Azadirachta indica (AI). AI, a popular medicinal plant commonly known as neem, has been studied for the green synthesis of NPs by using the capping and reducing agents secreted by the plant. Various phytochemicals identified in neem are capable of metal ion reduction. Green synthesis of NPs from neem is an eco-friendly and low-cost method. These NPs are reported to exhibit good antimicrobial activity. The review covers the preparation, characterization, and mechanism associated with the antibacterial, anticancer, and neurological diseases of the MNPs. Furthermore, the limitations associated with the existing NPs and the prospects of these NPs are also examined.

Indexed as

AzadirachtaGreen Chemistry TechnologyMetal NanoparticlesPlant ExtractsAnimalsAnti-Infective AgentsHumansAnti-Infective AgentsPlant ExtractsantibacterialanticancerAzadirachta indicablood brain barriermetallic nanoparticlesneurological disease

Identifiers

PMID38409695
OpenAlexW4392196718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.